Document is current

Investigation of Biowaivers for Immediate Release Formulations Containing BCS III Drugs, Acyclovir, Atenolol, and Ciprofloxacin Hydrochloride, Using Dissolution Testing

Crossref DOI link: https://doi.org/10.1208/s12249-016-0520-4

Published Online: 2016-04-01

Published Print: 2017-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy